Influence of the COVID-19 Pandemic on Quality of Life of Patients with Parkinson’s Disease

Table 3

Comparison of PDQ-39 outcomes between during and after epidemic prevention and control in patients who could easily receive doctor’s guidance and those who found it difficult.

Variables		During epidemic prevention and control	After epidemic prevention and control	t value	Sig
“Easy to get doctor’s guidance” subgroup (n = 33)	Mobility	19.33 ± 3.24	16.58 ± 3.70	6.273	< 0.001
	ADL	11.88 ± 2.36	10.82 ± 3.19	2.726	0.010
	Emotional well-being	11.91 ± 1.86	10.73 ± 2.39	3.750	0.001
	Stigma	7.85 ± 1.72	7.30 ± 2.04	1.578	0.124
	Social support	5.55 ± 1.50	5.39 ± 1.78	0.645	0.523
	Cognition	7.73 ± 1.94	7.42 ± 2.05	0.796	0.432
	Communication	5.48 ± 1.40	5.55 ± 1.77	−0.201	0.842
	Bodily discomfort	5.88 ± 1.58	5.61 ± 1.80	0.851	0.401
	Total score	75.61 ± 9.08	69.39 ± 9.11	10.362	< 0.001
“Difficult to get doctor’s guidance” subgroup (n = 75)	Mobility	20.89 ± 3.34	15.67 ± 3.30	16.832	< 0.001
	ADL	13.11 ± 2.28	10.23 ± 2.31	9.539	< 0.001
	Emotional well-being	12.77 ± 1.79	9.57 ± 2.36	12.461	< 0.001
	Stigma	8.93 ± 1.80	7.24 ± 1.97	9.153	< 0.001
	Social support	6.67 ± 1.33	6.35 ± 1.80	1.838	0.070
	Cognition	8.68 ± 1.93	6.69 ± 2.05	10.388	< 0.001
	Communication	6.16 ± 1.58	4.88 ± 1.72	5.514	< 0.001
	Bodily discomfort	6.57 ± 1.69	3.84 ± 1.33	15.320	< 0.001
	Total score	83.79 ± 7.94	64.47 ± 8.14	29.958	< 0.001